Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01760759 · ClinicalTrials.gov registry record · NA
Antiretroviral Therapy Adherence and Secondary Prevention of Human Immunodeficiency Virus
A NA study, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT01760759 is a NA study that has completed, run by UConn Health. The registered enrollment target is 104 participants.
The verdict
NCT01760759, a NA study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
In this study, investigators propose to randomize 165 human immunodeficiency virus positive patients to one of three 16-week treatment conditions: (1) standard care; (2) standard care + cell phone-based adherence reminders; or (3) standard care + cell phone-based adherence reminders and contingency management. In this latter condition, patients will earn reinforcement for sending in time- and date-stamped self videos of antiretroviral therapy medication ingestion. Primary outcomes will include viral loads and self-report measures of adherence, and effects will be evaluated both during the treatment period and throughout a one-year follow-up. Investigators hypothesize that the cell phone reminder condition will improve adherence relative to standard care, and the cell phone reminder plus contingency management condition will have the best outcomes. Results from this study may have widespread implications for the use of cell phones as a novel technology to improve initial adherence to antiretroviral therapy, thereby reducing the spread of drug resistant human immunodeficiency virus strains to the community.
Interventions
- BEHAVIORAL cell phone reminders
- BEHAVIORAL contingency management for adherence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2012-11 |
| Est. Completion | 2019-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01760759
The ClinicalTrials.gov registry entry for NCT01760759 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which cell phone reminders is the first listed.
NCT01760759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01760759 about?
NCT01760759 is a clinical study titled "Antiretroviral Therapy Adherence and Secondary Prevention of Human Immunodeficiency Virus". In this study, investigators propose to randomize 165 human immunodeficiency virus positive patients to one of three 16-week treatment conditions: (1) standard care; (2) standard care + cell phone-based adherence reminders; or (3) standard care + cell phone-based adherence reminders and contingency ...
What is the current status of trial NCT01760759?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2012-11. Estimated completion is 2019-04.
What interventions are being tested in trial NCT01760759?
The interventions under investigation include: cell phone reminders (BEHAVIORAL), contingency management for adherence (BEHAVIORAL).
Who is sponsoring clinical trial NCT01760759?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.